Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 25

Trial Status

Completed1
Recruiting3
Other2

Role Distribution

Principal Investigator6
PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT06121180Phase 2Recruiting
Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
Metastatic Uveal Melanoma
PrincipalinvestigatorStart date: 2024-11-04
NCT06295159Phase 2Recruiting
Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma
Advanced MelanomaMelanomaMelanoma Stage III+1 more
PrincipalinvestigatorStart date: 2024-05-17
NCT05170334Phase 2Active Not Recruiting
Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma
Metastatic Uveal Melanoma
PrincipalinvestigatorStart date: 2021-12-15
NCT04975152Phase 1Recruiting
Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma
Cutaneous Squamous Cell CarcinomaMerkel Cell Carcinoma
PrincipalinvestigatorStart date: 2021-10-22
NCT04562129Phase 2Active Not Recruiting
IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients
Inoperable DiseaseMelanoma Stage IIIMelanoma Stage IV
PrincipalinvestigatorStart date: 2020-09-24

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT06121180Phase 2PrincipalInvestigator

Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma

Metastatic Uveal Melanoma
Recruiting
NCT06295159Phase 2PrincipalInvestigator

Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma

Advanced MelanomaMelanomaMelanoma Stage III+1 more
Recruiting
NCT05170334Phase 2PrincipalInvestigator

Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma

Metastatic Uveal Melanoma
Active Not Recruiting
NCT04975152Phase 1PrincipalInvestigator

Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma

Cutaneous Squamous Cell CarcinomaMerkel Cell Carcinoma
Recruiting
NCT04526730Phase 2PrincipalInvestigator

Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients

Melanoma
Completed
NCT04562129Phase 2PrincipalInvestigator

IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients

Inoperable DiseaseMelanoma Stage IIIMelanoma Stage IV
Active Not Recruiting

All 6 trials loaded